Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
Companies
» Company Monitoring Page for Novartis
Company Monitoring Page for Novartis
latest headlines for company on cafepharma
Novartis manufacturing facility in North Carolina gets FDA all-clear to produce, ship gene therapies
Endpoints
Tue, 04/5/22 - 11:33 pm
Tags:
Novartis
,
gene therapy
,
North Carolina
,
FDA
,
Zolgensma
ACC 2022 – Astra’s cholesterol lowerer surprise comes just a little late
EP Vantage
Tue, 04/5/22 - 10:59 am
Tags:
AstraZeneca
,
Ionis Pharmaceuticals
,
AZD8233
,
cholesterol
,
ACC
,
Amgen
,
Sanofi
,
Novartis
,
Regeneron
In major shake-up, Novartis combines pharma and oncology units, leaving 3 top execs without jobs
Fierce Pharma
Mon, 04/4/22 - 11:00 am
Tags:
Novartis
,
layoffs
,
oncology
,
restructuring
Novartis' radiopharma drug wins approval in tough-to-treat prostate cancer patients
Endpoints
Wed, 03/23/22 - 11:01 pm
Tags:
Novartis
,
Lu-PSMA-617
,
radioligand
,
prostate cancer
Novartis' Sandoz, following Pfizer's lead, launches 2nd carcinogen-related drug recall this week
Fierce Pharma
Wed, 03/23/22 - 10:58 pm
Tags:
Novartis
,
Sandoz
,
product recalls
,
generics
Novo Nordisk and Novartis put Victoza patent suit to bed, teeing up Sandoz copycat by 2024
Fierce Pharma
Wed, 03/23/22 - 10:38 am
Tags:
Novo Nordisk
,
Novartis
,
Sandoz
,
Victoza
,
generics
,
patents
,
diabetes
Novartis takes next step in Russia, halting new trials and enrollment as Big Pharma responds to Ukraine invasion
Endpoints
Tue, 03/22/22 - 10:39 am
Tags:
Novartis
,
Russia
,
Ukraine
,
clinical trials
Pfizer and Novartis Are Betting On This Under-the-Radar Biotech. Should You?
Motley Fool
Sun, 03/20/22 - 11:03 pm
Tags:
Pfizer
,
Novartis
,
Voyager Therapeutics
,
AAV capsid
Novartis, Eli Lilly and AbbVie join growing list of Big Pharmas severing ties with Russia
Endpoints
Tue, 03/15/22 - 11:36 pm
Tags:
Russia
,
Ukraine
,
Novartis
,
Eli Lilly
,
AbbVie
New Data Reinforces Impact of Novartis' Gene Therapy on SMA
BioSpace
Mon, 03/14/22 - 10:46 am
Tags:
Novartis
,
gene therapy
,
spinal muscular atrophy
,
Zolgensma
Sandoz bulks up ahead of possible sale with Coalesce buy
Pharmaforum
Mon, 03/14/22 - 10:21 am
Tags:
Novartis
,
Sandoz
,
generics
,
M&A
,
Coalesce Product Development
Novartis puts contract manufacturing ambitions on display with deal to produce Carisma's cell therapy
Fierce Pharma
Thu, 03/10/22 - 10:35 am
Tags:
Novartis
,
contract manufacturing
,
Carisma Therapeutics
,
solid tumors
,
CAR-M
Novartis eyes next-gen AAV gene therapies in $1.75B Voyager biobucks pact
Fierce Biotech
Tue, 03/8/22 - 10:07 am
Tags:
Novartis
,
Voyager Therapeutics
,
biobucks
,
gene therapy
,
AAV gene therapy
BMS, Novartis, Akebia and more face FDA approval decisions soon, with big sales on the line
Fierce Pharma
Thu, 03/3/22 - 10:33 am
Tags:
FDA
,
drug approvals
,
FibroGen
,
AstraZeneca
,
daprodustat
,
Bristol Myers Squibb
,
Opdivo
,
Roche
,
tiragolumab
,
Merck
,
favezelima
,
bInnovent
,
Eli Lilly
,
Akeso Biopharma
,
Sino Biopharmaceutical
,
Novartis
,
Ukoniq
,
TG Therapeutics
,
GW Pharmaceuticals
,
Marinus Pharmaceuticals
Novartis sells pair of manufacturing plants as Sandoz strategic review rolls on
Fierce Pharma
Thu, 03/3/22 - 10:19 am
Tags:
Novartis
,
drug manufacturing
,
Sandoz
Novartis backs Epsilogen's bid to turn 'Cinderella antibody' into new class of cancer drug
Fierce Biotech
Wed, 03/2/22 - 12:10 pm
Tags:
Novartis
,
antibodies
,
funding
,
cancer
,
Epsiologen
Oncologists on board for Novartis' prostate cancer radiotherapy, but logistics could hit uptake: survey
Fierce Pharma
Wed, 02/23/22 - 10:29 am
Tags:
Novartis
,
prostate cancer
,
oncologists
,
radioligand
,
177Lu-PSMA-617
Third Harmonic Bio Launches to Advance the Next Wave of Medicine for Allergy and Inflammation
BioSpace
Wed, 02/16/22 - 10:51 am
Tags:
Third Harmonic Bio
,
THB001
,
Novartis
,
allergy
,
chronic urticaria
Vas Narasimhan and Severin Schwan each claimed pay packets worth $12M+ for 2021
Endpoints
Sat, 02/12/22 - 11:49 pm
Tags:
Roche
,
Novartis
,
executive pay
,
Severin Schwan
,
Vas Narasimhan
Chasing Novartis and Roche, Ventus banks $140M to take inflammatory disease drug into the clinic
Fierce Biotech
Wed, 02/9/22 - 10:07 am
Tags:
Ventus Therapeutics
,
Novartis
,
Roche
,
funding
,
inflammation
Pages
« first
‹ previous
…
16
17
18
19
20
21
22
23
24
…
next ›
last »
last 30 twitter posts
current feelings about your job
job rating
*
1 - I hate my job
2
3
4
5
6
7 - I love my job
Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
please tell us why
*
your industry
*
your job title (optional)
your company
*
published
N/A
published
not published
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
cafepharma is a: rock, tree, site
*
Fill in the blank.